Sihem N. Benaboud - Publications

Piperacillin Population Pharmacokinetics in Children Supported With Extracorporeal Membrane Oxygenation.

Journal: Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies

Published: August 06, 2026

From guidelines to bedside: Oral amoxicillin dosing for Enterococcus faecalis bone and joint infections remains highly variable in clinical practice.

Journal: The Journal of infection

Published: May 19, 2026

A descriptive case series of hepatotoxicity associated with CFTR modulators and possible relevance of pharmacogenetic polymorphisms in cystic fibrosis patients.

Journal: British journal of clinical pharmacology

Published: March 18, 2026

Urinary rezafungin exposure: First human reports of quantification and early pharmacokinetic insights.

Journal: The Journal of infection

Published: March 13, 2026

Urinary Rezafungin Exposure: First Human Reports of Quantification and Early Pharmacokinetic Insights.

Journal: The Journal of infection

Published: March 13, 2026

Piperacillin Population Pharmacokinetics in Plasma and Peritoneal Fluid and Dosing Optimization in Children Undergoing Liver Transplant: An Optimome Study.

Journal: Clinical pharmacology and therapeutics

Published: January 27, 2026

Physiologically Based Pharmacokinetic Modeling of Elexacaftor/Tezacaftor/Ivacaftor in Infants With Cystic Fibrosis.

Journal: CPT: pharmacometrics & systems pharmacology

Published: October 24, 2025

Pregnancy-related effect on elexacaftor, tezacaftor and ivacaftor pharmacokinetics in women with cystic fibrosis.

Journal: British journal of clinical pharmacology

Published: October 14, 2025

Cefazolin population pharmacokinetics in children undergoing maintenance hemodialysis for kidney failure.

Journal: Antimicrobial agents and chemotherapy

Published: October 02, 2025

Maternal-Fetal Letermovir Exposure In Vivo and Physiologically Based Pharmacokinetic Modeling: A Rationale for Congenital Cytomegalovirus Therapy.

Journal: The Journal of infectious diseases

Published: August 15, 2025

Maternal-Fetal Letermovir Exposure in Vivo and PBPK-based: A Rationale for Congenital CMV Therapy.

Journal: The Journal of infectious diseases

Published: August 15, 2025

Pharmacokinetics of cefotaxime and its metabolite desacetyl-cefotaxime to optimize dosing in critically ill children and children with sickle cell disease.

Journal: The Journal of antimicrobial chemotherapy

Published: August 01, 2025